BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6375887)

  • 1. Detection and quantification of mitoxantrone in human organs. A case report.
    Roboz J; Paciucci PA; Silides D; Greaves J; Holland JF
    Cancer Chemother Pharmacol; 1984; 13(1):67-8. PubMed ID: 6375887
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics and metabolism of mitoxantrone in man.
    Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
    Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Ehninger G; Proksch B; Schiller E
    J Chromatogr; 1985 Jul; 342(1):119-27. PubMed ID: 4044741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
    Alberts DS; Peng YM; Bowden GT; Dalton WS; Mackel C
    Invest New Drugs; 1985; 3(2):101-7. PubMed ID: 4040505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of mitoxantrone in cancer patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Res; 1985 Apr; 45(4):1879-84. PubMed ID: 3978648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of mitoxantrone in patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():23-7. PubMed ID: 6661732
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs recently released in Belgium: mitoxantrone, gemfibrozil.
    Harvengt C
    Acta Clin Belg; 1986; 41(2):127-30. PubMed ID: 3463107
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone.
    Peng YM; Ormberg D; Alberts DS; Davis TP
    J Chromatogr; 1982 Dec; 233():235-47. PubMed ID: 7161336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.
    Lu K; Savaraj N; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):63-6. PubMed ID: 6733844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of mitoxantrone in the treatment of tumors].
    Klener P
    Cas Lek Cesk; 1984 Jul; 123(28):873. PubMed ID: 6488260
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical pharmacology of mitozantrone.
    Smyth JF; Macpherson JS; Warrington PS; Leonard RC; Wolf CR
    Cancer Chemother Pharmacol; 1986; 17(2):149-52. PubMed ID: 3719894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitoxantrone in the treatment of relapsed and refractory malignant lymphoma].
    Kimura I; Ohnoshi T; Hiraki S; Ueoka H; Toyata K; Miyamoto H; Yamane T; Ueno K; Murashima M
    Gan No Rinsho; 1985 May; 31(6 Suppl):767-73. PubMed ID: 4040985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.